Latest news with #ThyrocareTechnologies
Time of India
6 days ago
- Business
- Time of India
Thyrocare Technologies shares jump 13% after Q1 PAT surges 60% YoY
Shares of Thyrocare Technologies surged 13% to hit the day's high of Rs 1,357.85 on the NSE on Thursday following the company's Q1 earnings where it reported a 60% year-on-year jump in its net profit at Rs 38 crore versus Rs 24 crore in the year-ago period. The company's revenue from operations also surged in double-digits, rising by 23% to Rs 193 crore compared to Rs 157 crore in the corresponding quarter of the last financial year. 23%. Explore courses from Top Institutes in Please select course: Select a Course Category Others Degree Finance others healthcare Leadership Public Policy Design Thinking CXO Product Management MBA Project Management Cybersecurity MCA Artificial Intelligence Data Science Digital Marketing Data Science PGDM Operations Management Healthcare Management Skills you'll gain: Duration: 7 Months S P Jain Institute of Management and Research CERT-SPJIMR Exec Cert Prog in AI for Biz India Starts on undefined Get Details Skills you'll gain: Duration: 9 months IIM Lucknow SEPO - IIML CHRO India Starts on undefined Get Details Skills you'll gain: Duration: 7 Months S P Jain Institute of Management and Research CERT-SPJIMR Exec Cert Prog in AI for Biz India Starts on undefined Get Details by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like The Dark Truth Nobody Talks About trendingresults Undo The gross margin was reported at Rs 137 crore in the quarter under review versus Rs 111 crore in the year ago period, witnessing a 23% growth. The normalised EBITDA (before ESOP) stood at Rs 63 crore versus Rs 45 crore, a 42% YoY jump while the normalised EBITDA margin was reported at 33% in Q1FY26 versus 29% in Q1FY25. The consolidated Gross Margin stood at 71%, with reported EBITDA margin at 30%. Live Events The earnings were announced on Wednesday after market hours. The company said that its Pathology Business Franchise revenue grew by 20% YoY, while partnership revenue surged by 36% YoY. Total test volume reached 46.9 million in Q1FY26, reflecting a 15% YoY increase. The diagnostic company opened new labs in Bhagalpur, Kashmir and Roorkee in the quarter ended June 30, 2025. Thyrocare Technologies is an automated laboratory chain with presence across India. Thyrocare provides diagnostic services to laboratories and hospitals.
Business Standard
6 days ago
- Business
- Business Standard
Thyrocare Tech spurts as Q1 PAT jumps 61% YoY to Rs 39 cr
Thyrocare Technologies surged 11.30% to Rs 1,340.55 after the healthcare service provider reported a 61.07% increase in consolidated net profit to Rs 38.93 crore on a 23.02% rise in revenue from operations to Rs 193.03 crore in Q1 FY26 over Q1 FY25. Profit before tax stood at Rs 50.48 crore in Q1 FY26, registering a growth of 50.46% from Rs 33.55 crore recorded in Q1 FY25. Total expenses rose 16.45% YoY to Rs 147.45 crore during the quarter. Employee benefits expenses stood at Rs 33 crore (up 14.9%), while the cost of materials consumed was at Rs 55.41 crore (up 24.1% YoY) during the period under review. The company's revenue from Diagnostic Testing Services was at Rs 178.33 crore (up 24.52% YoY), while revenue from Imaging Services stood at Rs 14.04 crore (up 7.67% YoY) in Q1 FY26. Reported EBITDA improved 37% YoY to Rs 57.46 crore in the June 2025 quarter from Rs 42.01 crore reported in the corresponding period the previous year. EBITDA margin increased to 30% in Q1 FY26 compared to 27% reported in the corresponding quarter last fiscal year. Meanwhile, the company announced the appointment of Vikram Gupta as the chief financial officer (CFO) of the company, effective from 24 July 2025. Thyrocare Technologies is engaged in the business of the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories, and hospitals in India.
&w=3840&q=100)
Business Standard
6 days ago
- Business
- Business Standard
Thyrocare Technologies zooms 13%, hits 52-week high on posting Q1 results
Thyrocare Technologies shares zoomed 12.66 per cent in trade, hitting a 52-week high at ₹1,356.95 per share on the BSE. The northward movement in the stock came after the company reported its Q1FY6 results. At 11:23 AM, Thyrocare Technologies' share price was trading 10.61 per cent higher at ₹1,332.25 per share on BSE. In comparison, BSE Sensex was down 0.4 per cent at 82,393.27. Thyrocare Technologies Q1 results Thyrocare Technologies reported its Q1FY26 results on Wednesday, July 23, 2025, after market hours. In the June quarter (Q1FY26), the company registered a 62 per cent rise in the consolidated net profit year-on-year (Y-o-Y) to ₹38.06 crore as compared to ₹23.47 crore. Its revenue from operations stood at ₹193.03 crore, up 23 per cent, from ₹156.91 crore a year ago. Its reported Earnings before interest, tax, depreciation and amortisation (Ebitda) for the quarter under review stood at ₹57.46 crore, as against ₹42.01 crore a year ago, up 37 per cent. Gross margin flat stood at 71 per cent Y-o-Y. Brokerage view on Thyrocare Technologies InCred Equities has increased the target price on Thyrocare Technologies to ₹1,400 per share from ₹1,010 as it believes the stock is currently due for a rerating. The brokerage has revised its earnings per shre share estimates upwards for FY26F/27F by 6 per cent/8 per cent, respectively, on the back of a significant turnaround in its business and strong performance. About Thyrocare Thyrocare Technologies is a laboratory chain with a strong presence PAN India. Thyrocare focuses on providing quality and affordable diagnostic services to laboratories and hospitals. Many laboratories and hospital brands all over India use the comprehensive test profile menu offered by Thyrocare. Thyrocare has an extensive network of laboratories across PAN India. Thyrocare has a Quarterly active franchise count of 9,500+ and processed 46.9mn+ diagnostic and screening investigations in Q1FY26. Thyrocare is one of the first Indian diagnostic laboratories to obtain internationally renowned quality accreditations including ISO 9001-2000 rating as early as 2001, which was upgraded to ISO 9001:2015 and National Accreditation Board for Testing and Calibration Laboratories (NABL) and College of American Pathologists (CAP) accreditations in 2005.
Business Upturn
7 days ago
- Business
- Business Upturn
Thyrocare shares rally over 7% as Q1 net profit rises 62% YoY Rs 38.06 crore, revenue up 23% YoY
Shares of Thyrocare Technologies surged more than 7% in early trade after the company posted a solid set of numbers for the June quarter of FY26, driven by double-digit growth in both revenue and profit. As of 9:40 AM, the shares were trading 7.26% higher at Rs 1,293.00. Thyrocare's consolidated revenue jumped 23% year-on-year (YoY) to ₹193.03 crore in Q1FY26, up from ₹156.91 crore in the same quarter last year. The strong topline growth was mainly led by its pathology business, which grew 25% YoY, while the radiology segment saw a moderate 6% uptick. Within pathology, both business models performed well—franchise revenue rose 20% YoY, and the partnership model reported a sharp 36% YoY growth. The company also processed 46.9 million diagnostic tests during the quarter, reflecting a 15% increase over Q1FY25. On the profitability front, Thyrocare reported normalized EBITDA (excluding ESOP costs) of ₹63.35 crore, up 42% YoY. Including all costs, EBITDA came in at ₹57.46 crore—marking a 37% increase. Net profit (PAT), including exceptional items, jumped 62% YoY to ₹38.06 crore. In terms of expansion, Thyrocare added new labs in Bhagalpur, Kashmir, and Roorkee, bolstering its presence in Tier-2 and Tier-3 cities—an area of increasing focus for the company as it looks to scale its reach beyond metro markets. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Standard
23-07-2025
- Business
- Business Standard
Thyrocare Technologies consolidated net profit rises 61.07% in the June 2025 quarter
Sales rise 23.02% to Rs 193.03 croreNet profit of Thyrocare Technologies rose 61.07% to Rs 38.93 crore in the quarter ended June 2025 as against Rs 24.17 crore during the previous quarter ended June 2024. Sales rose 23.02% to Rs 193.03 crore in the quarter ended June 2025 as against Rs 156.91 crore during the previous quarter ended June EndedJun. 2025Jun. 2024% 23 OPM %29.9326.95 -PBDT61.8944.91 38 PBT50.4833.55 50 NP38.9324.17 61 Powered by Capital Market - Live News
